$1 is cheap as chips when you consider the anticipated trials. COH paper suggests that Bisantrene is the drug of choice, rivalling thousands of other drugs. My honest opinion has Race with a market cap of $500m in the very near term, by December in my reckoning. Lots of data already proves that Bisantrene works. The team at Race give me no reason to be fearful of the future.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.005(0.44%) |
Mkt cap ! $199.8M | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.18 | $1.14 | $68.96K | 59.75K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3718 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 1775 | 1 |
View Market Depth
| Last trade - 15.49pm 18/07/2025 (20 minute delay) ? |
| RAC (ASX) Chart |